Patents by Inventor Malini Viswanathan

Malini Viswanathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA
    Publication number: 20190241961
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Application
    Filed: September 15, 2017
    Publication date: August 8, 2019
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur
  • Plasma kallikrein binding proteins
    Patent number: 10370453
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: August 6, 2019
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Methods of inhibiting plasma kallikrein in edema patient
    Patent number: 10336832
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: July 2, 2019
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20180305454
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Application
    Filed: December 4, 2017
    Publication date: October 25, 2018
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20180037664
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: September 15, 2017
    Publication date: February 8, 2018
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20180037666
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: September 15, 2017
    Publication date: February 8, 2018
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20180037665
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: September 15, 2017
    Publication date: February 8, 2018
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Methods of producing antibodies to neonatal Fc receptor (FcRn)
    Patent number: 9862768
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: January 9, 2018
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • COLLAGEN 7 AND RELATED METHODS
    Publication number: 20180002401
    Abstract: Disclosed are methods of making collagen 7, or functional fragments thereof, as well as collagen 7, and functional fragments thereof produced by such methods, nucleic acids encoding collagen 7, and functional fragments thereof, as well as vectors and host cells comprising such nucleic acids.
    Type: Application
    Filed: May 16, 2017
    Publication date: January 4, 2018
    Inventors: Mark De Souza, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20180002449
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: September 15, 2017
    Publication date: January 4, 2018
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20180002448
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: September 15, 2017
    Publication date: January 4, 2018
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20180002447
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: September 15, 2017
    Publication date: January 4, 2018
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Collagen 7 and related methods
    Patent number: 9676837
    Abstract: Disclosed are methods of making collagen 7, or functional fragments thereof, as well as collagen 7, and functional fragments thereof produced by such methods, nucleic acids encoding collagen 7, and functional fragments thereof, as well as vectors and host cells comprising such nucleic acids.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: June 13, 2017
    Assignee: Shire Human Genetic Therapies, Inc.
    Inventors: Malini Viswanathan, Mark DeSouza
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20160304608
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Application
    Filed: April 27, 2016
    Publication date: October 20, 2016
    Inventors: Daniel J. SEXTON, Christopher TENHOOR, Malini VISWANATHAN
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20160222109
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: December 29, 2015
    Publication date: August 4, 2016
    Applicants: Dyax Corp., Biogen Hemophilia Inc.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James M. McGivney, Kevin A. McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20160222110
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: December 29, 2015
    Publication date: August 4, 2016
    Applicants: DYAX CORP., BIOGEN HEMOPHILIA INC.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James M. McGivney, Kevin A. McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20160222108
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: December 22, 2015
    Publication date: August 4, 2016
    Applicants: DYAX CORP., BIOGEN HEMOPHILIA INC.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James M. McGivney, Kevin A. McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20160222112
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: December 30, 2015
    Publication date: August 4, 2016
    Applicants: DYAX CORP., BIOGEN HEMOPHILIA INC.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James M. McGivney, Kevin A. McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20160222111
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: December 30, 2015
    Publication date: August 4, 2016
    Applicants: DYAX CORP., BIOGEN HEMOPHILIA INC.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James M. McGivney, Kevin A. McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20160194397
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: December 31, 2015
    Publication date: July 7, 2016
    Applicants: DYAX CORP., BIOGEN HEMOPHILIA INC.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James M. McGivney, Kevin A. McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan